Zobrazeno 1 - 10
of 296
pro vyhledávání: ''
Autor:
Minoru Uebayashi, Hiroya Kobayashi, Yasuko Mizuta, Kazuma Kishi, Nobuyuki Ehira, Shoya Shiratori, Shiho Kaneko, Akihisa Nakamura, Kana Matsuda, Masataka Yagisawa
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-6 (2021)
Background Olmesartan, which is an angiotensin II receptor blocker, reportedly causes spruelike enteropathy, with intestinal villous atrophy as its typical histopathological finding. Interestingly, collagenous and/or lymphocytic gastritis and colitis
Autor:
Jun-Te Hsu, Puo-Hsien Le, Ming-Yao Su, Chien-Ming Chen, Meng-Wu Chung, Chia-Jung Kuo, Cheng-Tang Chiu, Ren-Chin Wu
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background Intestinal perforations and fistulas are common complications of Crohn’s disease. However, chronic perforation with peritoneal space to rectal and vaginal fistulas have not been previously reported. Case presentation A 38-year-old female
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background The purpose of this study was to compare short-course radiotherapy (SC) or neoadjuvant long-course chemoradiotherapy (LC) treatment for locally advanced rectal cancer patients. Methods Patients with a diagnosis of locally advanced rectal c
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background To investigate the efficacy and safety of dexamethasone-lipiodol emulsion in the prevention of post-embolization syndrome after TACE. Method The data of 255 patients who underwent TACE in the interventional department from June 2017 to Jun
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background Epstein–Barr virus (EBV)-associated NK/T-cell lymphoproliferative disorder (LPD) involving the gastrointestinal tract is rarely observed in individuals with normal immunity. The atypical clinical, colonoscopic manifestations often confus
Autor:
Dimitrios C. Ziogas, Despoina Pouloudi, Ioanna Delladetsima, Dionysia N. Zouki, Stratigoula Sakellariou, Helen Gogas
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background Immune checkpoint inhibitors (ICPIs) have changed the way advanced malignancies are currently confronted, improving cancer patients’ outcomes but also generating distinct immune-related (ir) adverse events. ICPIs-induced colitis is a com
Autor:
H Grümmer, Tim Fischer, Susanne Hohenberger, Niels Teich, Eric Jörgensen, Frank Holtkamp-Endemann, Thomas Liceni
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease with recurrent episodes of debilitating symptoms negatively affecting work productivity and health-related quality of life (HRQoL). The use of biologics in UC treatment improv
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background Serum hepatitis B core-related antigen (HBcrAg) is a potential surrogate marker for intra-hepatic covalently-closed circular DNA in chronic hepatitis B (CHB). We aimed to study the profiles of serum HBcrAg in CHB patients treated with firs
Autor:
Atsushi Yoshida, Yasuhiro Morita, Hisashi Hirayana, Akira Andoh, Kenichiro Takahashi, Shigeki Bamba, Osamu Inatomi, Takayuki Imai
Publikováno v:
BMC Gastroenterology. 22
Backgrounds:Optimal concentration of ustekinumab (UST) predicting endoscopic remission has not been fully investigated in Crohn's disease (CD). We aimed to identify the optimal UST trough levels predicting clinical, laboratory and endoscopic remissio
Autor:
Qiu-Ming Wang, Xiao-Yu Sun, Yang Li, Shunxiong Tang, Shoucheng He, Zhi-Jun Duan, Binbin Hou, Zhen Liu, Qing-Yong Chang
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Gastroenterology
BMC Gastroenterology
BackgroundPortal hypertension (PH) is the main cause of complications and death in liver cirrhosis. The effect of oral administration of octreotide (OCT), a drug that reduces PH by the constriction of mesenteric arteries, is limited by a remarkable i